Skip to content
-
NASP Applauds the Introduction of Bipartisan Legislation to Reduce Drug Costs and Support Medication Access for Seniors with Life-Threatening Specialized Conditions
May 27, 2021
This week, a bipartisan group of lawmakers in the U.S. House and Senate introduced legislation to rein in the high cost of prescription drugs and support the needs of specialty pharmacy patients living with life-altering and life-threatening specialty medical conditions. read more
-
NASP Comments on CMS Most Favored Nation (MFN) Model Interim Final Rule (CMS-5528-IFC)
Feb 18, 2021
The National Association of Specialty Pharmacy (NASP) submitted comments on the Center for Medicare and Medicaid... read more
-
Pharmaceutical Supply and Payment Chain Coalition Letter to President Biden
Jan 21, 2021
On January 14, 2021 the National Association of Specialty Pharmacy (NASP) in part of the Pharmaceutical... read more
-
NASP Comments on the proposed rule: “Medicare Program; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Policy Issues and Level II of the Healthcare Common Procedure Coding System (HCPCS)”
Jan 05, 2021
The National Association of Specialty Pharmacy (NASP) is pleased to provide comments in response to proposed... read more
-
NASP Comments on Health and Human Services (HHS) Request for Information (RFI) on Regulatory Relief to Support Economic Recovery
Dec 28, 2020
The National Association of Specialty Pharmacy (NASP) is pleased to provide comments in response to the... read more
-
Summary on the U.S. Supreme Court’s Opinion on Rutledge v. PCMA
Dec 10, 2020
WASHINGTON, DC (December 10, 2020) – Today, the United States Supreme Court issued its opinion in... read more
-
Pharmacy Groups Say New Rebate Rule Does Not Do Enough to Support Patients
Nov 24, 2020
WASHINGTON, DC (November 24, 2020) – Today the country’s leading pharmacy groups issued this statement on... read more
-
NASP Supports the SAFE TO WORK ACT
Jul 30, 2020
WASHINGTON DC, (July 30, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
-
Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees
Jul 29, 2020
WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
-
NASP Submits Comments to CMS
Jul 23, 2020
WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more